Introduction: To evaluate the efficacy of adjunctive tamsulosin therapy after extracorporeal shockwave lithotripsy (SWL) for renal stones. Materials and Methods: This prospective study was conducted on patients who underwent single-session SWL for solitary renal stone less than 20 mm. Post-SWL, patients were randomly divided into 2 groups; the tamsulosin group (TG), received a daily dose of tamsulosin 0.4 mg, for a maximum of 12 weeks, with post-SWL traditional analgesia and control group (CG), received the traditional analgesia alone. Results: The study enrolled 271 patients and eventually only 249 (123 in TG and 126 in CG) completed the study. The overall stone free rate was 73.5%: 78.0% in TG and 69.0% in CG (p = 0.108). In TG, 8.1% of patients experienced at least one episode of acute renal/ureteral colic compared with 19.8% of controls (p = 0.008). The mean cumulative analgesia dosage per subject was 313 mg in TG and 346 mg in CG (p < 0.001). Overall, 14 patients developed steinstrasse and 6 of them (all in CG) needed urgent intervention (p = 0.031). Conclusions: Daily tamsulosin therapy does not enhance the clearance of stone fragments but decreases the pain episodes, analgesia dosage and need for adjuvant intervention after SWL for renal stones.

1.
Ramello A, Vitale C, Marangella M: Epidemiology of nephrolithiasis. J Nephrol 2000;13(suppl 3):S45-S50.
2.
Aydemir H, Budak S, Kumsar Ş, et al: Efficacy of surgical techniques and factors affecting residual stone rate in the treatment of kidney stones. Turk J Urol 2014;40:144-149.
3.
Durner L, Bach C, El Howairis Mel F, et al: Current trends in urolithiasis treatment in various European health systems. Urol Int 2016;96:125-131.
4.
Chaussy C, Fuchs G: [Extracorporeal lithotripsy in the treatment of renal lithiasis. 5 years' experience]. J Urol (Paris) 1986;92:339-343.
5.
Wu H, Wang J, Lu J, et al: Treatment of renal stones ≥20 mm with extracorporeal shock wave lithotripsy. Urol Int 2016;96:99-105.
6.
Gerber R, Studer UE, Danuser H: Is newer always better? A comparative study of 3 lithotriptor generations. J Urol 2005;173:2013-2016.
7.
Graber SF, Danuser H, Hochreiter WW, et al: A prospective randomized trial comparing 2 lithotriptors for stone disintegration and induced renal trauma. J Urol 2003;169:54-57.
8.
Portis AJ, Yan Y, Pattaras JG, et al: Matched pair analysis of shock wave lithotripsy effectiveness for comparison of lithotriptors. J Urol 2003;169:58-62.
9.
Skolarikos A, Grivas N, Kallidonis P, et al: The efficacy of medical expulsive therapy (MET) in improving stone-free rate and stone expulsion time, after extracorporeal shock wave lithotripsy (SWL) for upper urinary stones: a systematic review and meta-analysis. Urology 2015;86:1057-1064.
10.
Turk C, Knoll T, Petric A, et al: EAU Guidelines on Urolithiasis 2013. http://www.uroweb.org/gls/pdf/21_Urolithiasis_LR.pdf.
11.
Mohamed HI: The efficacy of tamsulosin therapy after extracorporeal shock-wave lithotripsy for ureteric calculi: a prospective randomised, controlled study. Arab J Urol 2013;11:398-404.
12.
Falahatkar S, Khosropanah I, Vajary AD, et al: Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi? J Endourol 2011;25:495-498.
13.
Hossain MZ, Biswas NP, Islam MS, et al: Effect of tamsulosin on stone clearance after extra-corporeal shock wave lithotripsy. Bangladesh Med J 2011;40:27-32.
14.
Losek RL, Mauro LS: Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi. Ann Pharmacother 2008;42:692-697.
15.
Gravina GL, Costa AM, Ronchi P, et al: Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 2005;66:24-28.
16.
Sivula A, Lehtonen T: Spontaneous passage of artificial concretions applied in the rabbit ureter. Scand J Urol Nephrol 1967;1:259-263.
17.
Miller OF, Kane CJ: Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999;162(3 pt 1):688-690; discussion 690-691.
18.
Seitz C, Liatsikos E, Porpiglia F, et al: Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 2009;56:455-471.
19.
Zheng S, Liu LR, Yuan HC, et al: Tamsulosin as adjunctive treatment after shockwave lithotripsy in patients with upper urinary tract stones: a systematic review and meta-analysis. Scand J Urol Nephrol 2010;44:425-432.
20.
Itoh Y, Kojima Y, Yasui T, et al: Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 2007;14:749-753.
21.
Park HK, Choi EY, Jeong BC, et al: Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. Urol Res 2007;35:325-329.
22.
Micali S, Grande M, Sighinolfi MC, et al: Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res 2007;35:133-137.
23.
Gravas S, Tzortzis V, Karatzas A, et al: The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 2007;35:231-235.
24.
Wang CJ, Huang SW, Chang CH: Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones. Urol Int 2009;82:166-169.
25.
Zaytoun OM, Yakoubi R, Zahran AR, et al: Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial. Urol Res 2012;40:327-332.
26.
Naja V, Agarwal MM, Mandal AK, et al: Tamsulosin facilitates earlier clearance of stone fragments and reduces pain after shockwave lithotripsy for renal calculi: results from an open-label randomized study. Urology 2008;72:1006-1011.
27.
Lucio J 2nd, Korkes F, Lopes-Neto AC, et al: Steinstrasse predictive factors and outcomes after extracorporeal shockwave lithotripsy. Int Braz J Urol 2011;37:477-482.
28.
Madbouly K, Sheir KZ, Elsobky E, et al: Risk factors for the formation of a steinstrasse after extracorporeal shock wave lithotripsy: a statistical model. J Urol 2002;167:1239-1242.
29.
Resim S, Ekerbicer HC, Ciftci A: Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 2005;66:945-948.
30.
Moursy E, Gamal WM, Abuzeid A: Tamsulosin as an expulsive therapy for steinstrasse after extracorporeal shock wave lithotripsy: a randomized controlled study. Scand J Urol Nephrol 2010;44:315-319.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.